Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Guidant to use CardioVascular's Focus technology:

This article was originally published in Clinica

Executive Summary

Guidant's Vascular Intervention Group is to develop and market CardioVascular Dynamics' Focus technology in products designed to deliver Guidant's coronary and vascular stents. Guidant has exclusive rights to the technology for stent delivery in the US and Canada, and co-exclusive rights with CVD for the rest of the world. Irvine, California-based CVD will continue to sell the technology for balloon dilation procedures in the US and all applications elsewhere. Guidant will make payments to CVD, linked to the transfer of manufacturing technology and know-how, as well as royalties. CVD says its technology provides a unique method of performing coronary stent delivery using both low and high balloon inflation pressures on a single catheter.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT081796

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel